Fuda Cancer Hospital
Fuda Cancer Hospital
Қытай, Гуаңджоу
| Қытай | Түркия | Австрия | |
| Бауырдың химиоэмболизациясы | бастап $6,200 | бастап $7,500 | бастап $16,000 |
| Бауырдың радиожиілік абляциясы (БРА бауыр) | бастап $5,500 | бастап $3,500 | бастап $12,000 |
| Бауырды резекциялау | бастап $18,500 | бастап $11,700 | бастап $35,000 |
| Бауыр қатерлі ісігінде резекция | бастап $21,500 | бастап $10,800 | бастап $40,000 |
| Бауыр рагында химиялық терапия | бастап $3,500 | бастап $1,800 | - |
Сіз Bookimed қызметтері үшін төлемейсіз. бауырдағы метастаздардың емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек бауырдағы метастаздардың жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. бауырдағы метастаздардың емдеу кезінде Сіз басқа елде жалғыз қалмайсыз.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Chinese oncology centers provide advanced Western treatments for liver metastases, focusing on minimally invasive ablation, catheter-directed therapies, and surgical resection. Accredited facilities like Fuda Cancer Hospital utilize JCI-standard protocols. These include NanoKnife and cryosurgery to target tumors while preserving healthy liver tissue.
Bookimed Expert Insight: Data from Fuda Cancer Hospital reveals a specialized focus on late-stage cases often deemed inoperable elsewhere. While many centers prioritize standard resection, Fuda utilizes a high volume of non-thermal NanoKnife procedures. This approach is specifically effective for metastases located near major blood vessels where heat-based ablation or surgery risks internal damage. This specialization has attracted patients from over 100 countries seeking alternatives for complex tumor locations.
Patient Consensus: Patients note that leading centers often propose aggressive multidisciplinary sequencing, moving quickly from systemic therapy to local interventions. Many emphasize the importance of bringing original biopsy reports and genomic results to avoid repeat testing delays.
China offers advanced non-invasive radiation options like Proton Beam Therapy through a rapidly expanding network of specialized oncology centers. Facilities in Shanghai and Guangzhou utilize high-precision particle therapy to treat complex liver metastases. These institutions maintain international standards with Joint Commission International accreditations and advanced delivery systems.
Bookimed Expert Insight: While Proton Beam Therapy is a major draw, high-volume centers like Fuda Cancer Hospital often prioritize a combination of NanoKnife and vascular interventional therapy for liver metastases. Data shows these minimally invasive techniques are frequently selected over radiation for late-stage cases. Patients should verify if a facility's 400-bed capacity includes dedicated space for international oncology recovery.
Patient Consensus: Patients note that while newer technology is attractive, doctors often recommend Stereotactic Body Radiation Therapy (SBRT) for liver lesions. They emphasize bringing complete pathology reports to ensure the tumor location actually qualifies for proton treatment.
China integrates Traditional Chinese Medicine (TCM) for liver metastases as a supportive therapy alongside Western protocols. Chinese oncology programs follow national guidelines to combine TCM with chemotherapy, immunotherapy, and interventional procedures. These integrative methods aim to optimize tolerance, support liver function, and manage treatment side effects.
Bookimed Expert Insight: While many Chinese centers provide integrative care, hospitals with JCI accreditation like Fuda Cancer Hospital emphasize specialized technologies. They utilize cryosurgery and NanoKnife for liver lesions alongside supportive interventional therapies. Leading oncologists in China, such as Professor Liu Shi Xin at Xiamen Humanity Hospital, participate in both the Chinese Medical Association and the Chinese Anti-Cancer Association. This ensures that TCM integration remains strictly under the supervision of qualified Western-trained medical experts.
Patient Consensus: Patients note that TCM helps them feel less destroyed by improving appetite and energy levels during chemo. They emphasize that measurable results come from Western medicine, while herbs serve as a practical way to manage day-to-day comfort.